Hypoxia in Alzheimer 's disease: effects of hypoxia inducible factors

来源 :中国神经再生研究(英文版) | 被引量 : 0次 | 上传用户:skyaixiao
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Alzheimer\'s disease (AD), a common neurodegenerative disease, afflicts 26 million people worldwide currently with projection of a fourfold increase in this figure by the year 2050 (Brookmeyer et al., 2018). The majority of AD cases (95%) are sporadic, having the late-onset affecting those over 65 years old. About 15% among those 65 years and older suffer from AD, and the incidence of AD is close to 50% for those aged over 85 years (Brookmeyer et al., 2018). There are a number of changes in the ageing brain, such as reduced cerebral blood flow, white matter changes, iron overload, and neuroinflammation (Chen et al., 2010). The reduction of cerebral blood flow leads to hypoperfusion, thus causing cerebral hypoxia, which is a common vascular component among the AD risk factors. Prolonged and severe hypoxia can cause neuronal loss and memory impairment. It has been understood that patients with stroke are at risk of AD. Up to 1/3 of stroke survivors suffer from post stroke dementia (Mijajlovic et al., 2017). The most common cause of post stroke dementia are vascular dementia, AD and mixed dementia.
其他文献
A major feature of neurodegeneration is disruption of central nervous system homeostasis, during which microglia play diverse roles. In the central nervous system, microgliaserve as the first line of immune defense and function in synapse pruning, injury
Reconstitution of complex multi-tissue organs is one of the most impressive feats of biology and is observed across regeneration-competent vertebrate species, including teleost fish (e.g., zebrafish), urodeles (e.g., axolotls and newts), and some lizards.
期刊
Parkinson\'s disease (PD) is a neurodegenerative disorder characterized by accumulation of α-synuclein in neurons of the central nervous system (CNS). The pathogenesis of PD is complex and only partially understood. Initial evidence pointed to the basal
期刊
Myelination, remyelination and demyelination: modeling the in vitro drug discovery pipeline: Demyelination is a multifactorial event occurring in diseases primarily involving myelin forming cells (oligodendrocytes, OLs) and their precursors (oligodendrocy
期刊
The complex challenges of studying neurochemistry: Neurochemistry comprises the molecular and biochemical roles of a vast variety of chemical compounds, including amino acids, peptides, gaseous molecules, and small molecules such as monoamines, which are
期刊
Extract from the medicinal herb Withania somnifera (WS), commonly known as Ashwagandha, has therapeutic implications in various conditions such as infection, inflammation, cancer, stress, neurodegenerative diseases, heart disease, diabetes, and others. Wi
期刊
The regeneration of peripheral nervous system and central nervous system (CNS) neurons after injury remains challenging. We have come a long way since the identification of a 37 kDa protein specific for regenerating peripheral nervous system and CNS nerve
期刊
Dry eye disease (DED) is a multifactorial disease characterized by a loss of homeostasis of the tear film and accompanied by ocular symptoms, in which tear film instability and hyperosmolarity, ocular surface inflammation and damage, and neurosensory abno
期刊
Reactive oxygen species (ROS) and kynurenines: Kynurenines represent a relatively heterogenous group of tryptophan metabolites (Figure 1A). The amino acid tryptophan is metabolized in the humans by the kynurenine or serotonin pathway. For a long time, the
期刊
Decreased neuronal survival-signaling and brain damage: Stroke is a leading cause of death worldwide, the major cause of adult disability and second of dementia. In spite of the social and economic importance of this disorder, and after intense research,
期刊